AstraZeneca COVID-19 vaccine shows promise with the elderly

November 19, 2020 

Britain’s Oxford University and AstraZeneca coronavirus vaccine has produced a strong immune response among older people – and researchers expect to release late-stage trial results by Christmas, according to a report.

The data published in The Lancet medical journal Thursday suggest that people over 70 who are at higher risk of serious illness and death from the deadly bug could build a strong immunity, Reuters reported.

“The robust antibody and T-cell responses seen in older people in our study are encouraging,” said Maheshi Ramasamy, a consultant and co-lead investigator at the Oxford Vaccine Group.

“We hope that this means our vaccine will help to protect some of the most vulnerable people in society, but further research will be needed before we can be sure,” he added.

Researchers said Phase 3 trials are ongoing to confirm the findings and to test whether the shot protects against infection in a broad range of people, including those with underlying medical conditions.

Results should be known by Christmas, Oxford Vaccine Group director Andrew Pollard said, adding that it was too early to know whether and how well the inoculation works in preventing the disease.

“We’re still waiting to get to the point where we can do the analysis to just work out how well the vaccine can protect people, and we’re getting ever closer to that,” he told journalists.

“We are optimistic that we’ll be able to do that before Christmas, and obviously we’ll share that with you as soon as we can at that point,” Pollard added.

The Oxford-AstraZeneca vaccine candidate had been among the front-runners in global efforts to develop effective vaccines against COVID-19.

In the past few days, rival drugmakers Pfizer, BioNTech and Moderna have released data from late-stage trials that shows more than 90 percent efficacy.

“We’re not in a rush. We and it’s not a competition with the other developers,” Pollard said, adding that AstraZeneca would release headline efficacy data before it was published in an academic journal.

Unlike the Pfizer-BioNTech and Moderna vaccines, which use new technology known as messenger RNA, AstraZeneca’s is a viral vector shot made from a weakened version of a common cold virus.

The trial reported in The Lancet involved 560 healthy volunteers, with 160 aged 18-55, 160 aged 56-69 and 240 aged 70 or over, according to Reuters.

Latest News

December 2, 2020
Justice Department investigating 'bribery conspiracy scheme' involving presidential pardon, documents show

Heavily redacted documents did not show which individuals are under investigation in connection to the alleged scheme.

Read More
December 2, 2020
San Jose mayor apologizes for Thanksgiving family dinner, commits to ‘do better’

San Jose Mayor Sam Liccardo apologized on Tuesday for spending Thanksgiving with his family in apparent violation of state rules and said he will “commit do better.”

Read More
December 2, 2020
Whistleblowers claiming USPS threw out, backdated ballots before election

A conservative law firm says that several whistleblowers from the United States Postal Service have come forward, alleging that thousands of ballots in some states were backdated, tampered with, or tossed out ahead of the 2020 election, to the disservice of President Trump, despite the Justice Department has found no proof of widespread voter fraud. 

Read More
December 2, 2020
San Francisco Mayor London Breed attended French Laundry party the night after Gavin Newsom

San Francisco Mayor London Breed has officially joined the ranks of public officials who have been busted for breaking their own coronavirus guidelines.

Read More
December 2, 2020
Joe Manchin says 'Squad' could hamper $908B coronavirus relief

Sen. Joe Manchin warned on Tuesday that members of the progressive "Squad" will have some explaining to do the American people if they try to thwart efforts to pass bipartisan coronavirus legislation.

Read More
December 2, 2020
GOP leaders lay into Pelosi for marijuana legalization bill while COVID-19 relief remains uncertain

Republican lawmakers condemned House Speaker Nancy Pelosi after Democratic leadership announced that a bill to federally legalize marijuana will hit the House floor Wednesday.

Read More